The use of fibre-optic techniques in clinical diagnosis and visual assessment of experimental intrauterine therapy in mares.

Intrauterine fibroscopy was used in the clinical evaluation of 40 mares with established histories of subfertility. The average age of the mares was 12.2 years with a 2.8-year interval from last foaling in multiparous mares. Transluminal adhesions, endometrial cysts, diffuse fibrosis, fluid accumulation or myometrial tumours were found in 26 mares. When compared to other techniques, fibroscopy did not seem to be superior to uterine biopsy but had some advantage over rectal palpation as a single diagnostic technique. Only 3 mares failed to exhibit pathological findings when all 3 techniques were used. A second study was conducted to examine visually the effect of infusing various antibiotics and disinfectants into the uteri of clinically normal dioestrous mares. Fibre-optic examinations were performed before and after infusion of 3 mares/treatment. No gross pathological changes were seen 3 days after infusion of potassium penicillin, chloramphenicol succinate or a soluble oxytetracycline powder in a dextrose base. Lugol's solution caused severe inflammation, fibrin deposition, and ulceration of the endometrium. Ampicillin resulted in a white precipitate which adhered to the the endometrium for 10 days after treatment.     

Anticorps antispermatozo?des : indications, étiologies et applications en 2011, de l’exploration de l’infertilité au concept d’immunocontraception masculine

The present literature review aims at clarifying the techniques used in the screening of antisperm antibodies (ASAS), the value of screening at different physiological and pathological conditions, and the choice of infertility treatment in assisted reproduction. Moreover, studying the targets and the role of ASAS in infertility allowed for the development of antisperm contraceptive vaccines, which are found effective in some animal models and potentially usable in humans.     

The effect of isosorbide dinitrate on uterine and ovarian blood flow in cycling and early pregnant mares: A pilot study

Poor uterine perfusion has been proposed as a cause of infertility in mares. The objective of this study was to investigate the effect of isosorbide dinitrate (ISDN), a nitric oxide donor, on uterine and ovarian blood flow resistance during diestrus and early pregnancy in mares. Six Trotter mares, aged 7 to 14 years, were examined daily during the first 11 days of three diestrous periods, and five of those mares were also examined during the first 11 days of two pregnancies. Six mares randomly received a placebo, a low dose (30 mg, ISDN30), or a high dose of ISDN (60 mg, ISDN60) through three nonconsecutive cycles. The treatments were administered orally, every 12 hours from Day 1 to 11 of the cycle (Day 0 = ovulation). Five of the 6 mares received a placebo or 60 mg of ISDN orally every 12 hours from Day 1 to 11 of pregnancy. The mares were short cycled on Day 12 of each trial. Transrectal color Doppler was used to determine blood flow resistance semiquantitatively and expressed as pulsatility index. Mean pulsatility index of both uterine arteries combined and of the dominant (ipsilateral to the CL) ovarian artery was lower (treatment effects: P ≤ 0.01; time effects: P ≤ 0.002) in mares receiving 30 mg or 60 mg of ISDN compared with placebo-treated mares. Blood flow resistance in the dominant ovarian artery was lower in ISDN-treated pregnant mares than in placebo-treated pregnant and cycling mares (treatment effect: P = 0.04; time effect: P = 0.003). Isosorbide dinitrate increases uterine and ovarian perfusion in cycling mares and ovarian perfusion in early pregnant mares. Further studies are needed to investigate these effects in relation to fertility of the mare.     

Use of acupuncture in equine reproduction

The goal of this review is to provide evidence supporting the physiologic basis for the use of acupuncture as a treatment in equine reproduction, and to discuss current uses of acupuncture for the treatment of anestrus, urine pooling, uterine infection and/or fluid, infertility, maintenance of pregnancy, cryptorchidism, musculoskeletal pain, and poor libido in stallions. The benefits achieved through acupuncture treatment are thought to be a result of hormonal regulation, altered smooth muscle motility, and general stress and/or pain relief from musculoskeletal or environmental conditions.     

Morphologic Evaluation of Acute Endometritis in Mares with Differing Resistance to Uterine Infections

The study was designed to determine differences between normal mares and mares with endometrial pathology in the inflammatory response after bacterial challenge. Six normal mares (biopsy category I) and 4 mares with pathological endometrial changes (biopsy category II) were given an intrauterine infusion of β-hemolytic streptococci on the second day of estrus. All mares had a similar kind of inflammatory response after the bacterial inoculation as assessed by rectal and vaginal examinations. There were no significant differences in the amount of discharge, uterine tone, uterine size and cervical relaxation between the groups. Leukocytic response, as determined by endometrial smears and biopsies, was of the same magnitude in both groups. Two mares from the pathological group were not able to eliminate the infection, but had vaginal discharge and bacteriologically positive uterine swabs until the end of the experiment. It is concluded that the inability of some mares to clear uterine infections cannot be explained by a deficient inflammatory response.     

A survey of the fertility of Icelandic stallions

Very limited information is available on the breeding performance of Icelandic stallions, let alone the effect that management practices may have had on such performance. As an extensively kept, largely genetically isolated breed of horse it provides a good model for the study of factors that affect reproductive performance without the additional complication of selective breeding, infectious infertility and breed effect. A survey was conducted using 27 Icelandic stallions covering 1590 mares within the normal Icelandic breeding system (May to September). During the season, stallions cover mares within three periods of time, each period being of a similar length (average 35.5 days). During period 1, mares are covered in hand and at pasture. During periods 2 and 3, all mares are covered at pasture. The overall fertility rate for Icelandic stallions was calculated. The effect of a range of variables on fertility was investigated statistically using a number of models in an attempt to minimise the effect of confounding factors. An overall adjusted fertility rate for Icelandic stallions of 67.7% was obtained. The following factors were shown to have a significant effect on fertility: age of mare (P<0.001), training level of stallion (P<0.05) and method of breeding (P<0.05). For some individual stallions reproductive status of the mare also had a significant (P<0.001) effect. Many of these factors have been observed to effect FR in other more intensively managed equine populations. However, the less dramatic detrimental effect of age and the lack of a significant effect of mare reproductive status in most stallions suggests that infertility problems are less evident in Icelandic mares, possibly due to less emphasis on selection for athletic performance and the accepted culling of subfertile stock.     

浮针埋线联合推拿疗法对神经根型颈椎病疗效及对颈椎活动度、生理曲度变化的影响

摘要 目的：探讨与分析浮针埋线联合推拿疗法对神经根型颈椎病疗效及对颈椎活动度、生理曲度变化的影响。方法：2019年2月到2021年6月选择在本院诊治的神经根型颈椎病患者105例作为研究对象,根据1：1简单分配原则把患者分为浮针组53例与对照组52例。对照组给予推拿治疗,浮针组在对照组治疗的基础上给予浮针埋线治疗,两组都治疗观察21 d,记录患者颈椎活动度、生理曲度变化情况。结果：治疗后浮针组的总有效率为98.1 %,与对照组的86.5 %相比有明显提高（P<0.05）。浮针组与对照组治疗后的颈椎活动度评分明显低于治疗前,浮针组与对照组相比也明显降低（P<0.05）。浮针组与对照组治疗后的疼痛视觉模拟评分法（VAS）评分明显低于治疗前,颈椎日本骨科协会评估治疗分数（JOA）评分明显高于治疗前,治疗后浮针组与对照组对比也有明显差异（P<0.05）。浮针组与对照组治疗后的颈椎生理曲度明显高于治疗前,浮针组也明显高于对照组（P<0.05）。结论：浮针埋线联合推拿疗法在神经根型颈椎病患者的应用能促进缓解疼痛,改善颈椎功能,能提高治疗疗效,改善患者的颈椎活动度,还可促进颈椎生理曲度恢复正常。     

A low-level X chromosome mosaicism in mares, detected by chromosome painting

Fluorescence in situ hybridization with the use of the equine X whole chromosome painting probe was carried out on chromosome spreads originating from three mares with poor reproductive performance (infertility, miscarriage or stillbirth). The numbers of analysed spreads were high (105, 300 and 480) and in all three mares a low frequency of mosaicism was identified. The mares had the following karyotypes: 64,XX/63,X/65,XXX (93.6%/5.7%/0.7%), 64,XX/63,X (98.9%/1.1%) and 64,XX/63,X (94.3%/5.7%). The incidence and importance of the low percentage X chromosome mosaicism are discussed.     

Effect of serial intrauterine dimethyl sulfoxide infusions on the incidence of periglandular fibrosis in category II horse endometria

High concentrations of dimethyl sulfoxide (DMSO) have been shown to cause gross structural changes in collagen fibers in vitro. As endometrial fibrosis is a major cause of infertility in mares, the effect of serial DMSO infusions on periglandular fibrosis of Category II endometria was investigated. Initially, six mares with Category I endometria were serially infused with DMSO to determine whether such therapy would incite fibrosis. Four mares, serially infused with saline, served as controls in each experiment. One hundred milliliters of 75% DMSO was infused initially, followed by the same volume of 25% DMSO daily for 6 d. Endometrial biopsies obtained 21 d after the last infusion displayed no significant difference in the incidence of periglandular fibrosis when compared with the Day 0 biopsies. Examination of treated uteri at necropsy showed no gross evidence of adhesions or ulcerations.     

Ultrasonic anatomy and pathology of the equine uterus

The morphological and pathological status of the uterus in mares was evaluated using a linear-array ultrasound scanner, and the ultrasonic properties of the uterus were characterized. The uterus was examined each day in 16 mares, beginning at mid-diestrus. The uterus was recorded as having an ultrasonic morphology characteristic of diestrus (endometrial folds not distinguishable), estrus (prominent endometrial folds) or an intermediate stage (folds only moderately distinguishable). The number of mares with an intermediate or estrous image increased gradually between day -7 (2 14 mares; ovulation = day 0) and days -3 (11 16 ) and -2 (10 16 ) and then declined between days -2 and +1 (0 12 ). In another study, a large nonechogenic area (ejaculate) was visible in the uterine lumen immediately after mating in all of six mares. During the course of pregnancy diagnoses and hand-breeding, several pathological conditions of the uterus were first observed by ultrasound examination and confirmed by digital exploration of the uterus or at slaughter. Cysts contained nonechogenic material (fluid) and were usually compartmentalized. The purulent material associated with pyometria was relatively nonechogenic but contained echogenic spots. Mummified fetuses and remnants of fetal bones showed echogenic properties consistent with high tissue density. The results demonstrated that ultrasound technology provides a noninvasive form of visual access to the uterus to evaluate normal, morphological changes and to detect and study certain pathological processes.     

α1-肾上腺素受体介导交感神经对机体调节及针灸效应的研究情况分析

为明确近30年α_1-AR(a1-Adrenoceptor)介导交感神经对机体生理病理变化及针灸效应的研究情况,本文查阅CNKI数据库及Pubmed数据库,对近30年关于α_1-AR介导的交感神经对机体生理病理影响及针灸效应的研究情况进行系统回顾。发现α_1-AR不但介导交感神经对心脏的变力变时效应,以及血管平滑肌、膀胱括约肌和子宫平滑肌的收缩等生理效应的调节,还介导了心律失常、心肌肥大等病理过程,此外,α_1-AR还介导了针刺信号的传导,而且针刺还可以调节交感神经张力。说明机体的许多生理病理改变与α_1-AR及亚型的变化有密切关系,因此,深入研究α_1-AR将有助于阐释机体的生理病理机制,也为有效药物提供理论依据和相应的药理模型;对经脉穴位上α_1-AR的深入研究,有助于经络实质的探讨及针刺效应物质基础研究。     

Embryo loss following GnRH-induced ovulation in anovulatory mares

Two experiments were conducted using a 21-day GnRH analogue treatment regimen to induce ovulation in seasonally anovulatory mares. In Experiment 1, nontreated (n=20) and treated (n=83) mares were defined as having inactive ovaries (largest follicle相似文献   

Effects of deslorelin or hCG administration on reproductive performance in first postpartum estrus mares

A tendency for deslorelin implants to suppress subsequent follicular growth and delay return to estrus following induced ovulation has been documented in nonlactating mares. To investigate this phenomenon in lactating mares, 22 broodmares in southeast Texas were administered either deslorelin or hCG to induce ovulation in the first postpartum estrus during February and March 2001. Mares were teased daily and examined twice weekly (Tuesdays and Thursdays) by transrectal ultrasonography. When a follicle >35 mm diameter was detected on Tuesday, mares were treated with either 2,500 U hCG administered intravenously or with one implant (2.1 mg) deslorelin administered subcutaneously. Mares were bred every other day until ovulation was detected or until they ceased behavioral estrus, and were examined 16 days after treatment to detect pregnancy. Follicular measurements were recorded for all mares during each examination, and interestrous intervals were recorded for mares not becoming pregnant. Treatment of mares with either hCG or deslorelin resulted in similar ovulatory responses and pregnancy rates. Deslorelin-treated mares had fewer ovarian follicles >20 mm in diameter 16 days after treatment than hCG-treated mares (P < 0.01). Interestrous intervals for mares failing to become pregnant on foal heat breeding were prolonged in deslorelin-treated compared to hCG-treated mares (P < 0.01). Date of treatment was negatively correlated with length of the interestrous interval in deslorelin-treated mares (P < 0.01), but was not correlated with length of interestrous interval in hCG-treated mares (P > 0.10). All mares failing to become pregnant from foal heat breedings became pregnant from later breedings, but the parturition to conception interval was prolonged in deslorelin-treated compared to hCG-treated mares that did not become pregnant on foal heat (P < 0.01).     

When to refer an infertile mare to a theriogenologist

Most equine infertility cases can be solved with a methodical, thorough physical and reproductive examination and appropriate diagnostic laboratory aids. Repeated examinations may be needed in some cases to identify subtle anatomical abnormalities or irregularities between hormonal and physiological relationships of the reproductive tract. For pregnancy to occur, hormonal signaling must be exquisitely synchronized with physical changes of the reproductive tract and deposition of fertile semen in the uterus. Asynchrony of these events, infection, inflammation, previous trauma to the reproductive tract or "stress" can interfere with conception or maintenance of pregnancy. Infertile mares are presented for three common problems: (1) accumulation of intra-uterine fluid during or immediately after estrus; (2) long standing infection and/or chronic inflammation; or (3) irregular or no estrous cycles. By defining the problem, diagnostics can be chosen to determine the cause. Treatment protocols should be designed around the diagnosis and antibiotics, ecbolics or steroids should not be used indiscriminately. In all cases of mare infertility, semen quality needs to be determined to be satisfactory as a subfertile stallion bred to a subfertile mare greatly decreases the likelihood of pregnancy.     

Comparison of the effects of two GnRH antagonists on LH and FSH secretion,follicular growth and ovulation in the mare

The effects of two GnRH antagonists were tested in order to delay and/or synchronise ovulation in mares. Five mares received Antarelix (0.01 mg.kg(-1)), 5 mares received Cetrorelix (the same dose), 5 mares (control mares) received the vehicle intravenously, twice daily, for 8 days from the day the largest follicle reached 22 mm following prostaglandin administration. Ovulation was postponed in all mares injected with Antarelix (19.4 +/- 1.2 days after the beginning of the treatment) and in 2/5 mares injected with Cetrorelix (20 +/- 1 days) vs. 6.2 +/- 0.4 days in control mares. During the treatment, LH concentrations were strongly depressed in Antarelix and in Cetrorelix mares (1.6 +/- 0.1 and 3.8 +/- 0.5 ng.mL(-1) respectively vs. 21 +/- 2.5 ng.mL(-1) in control mares). In the 3 Cetrorelix mares which ovulated during the treatment. 2 initiated their LH surge at this moment. FSH concentrations were not affected in Antarelix or in Cetrorelix mares during the treatment (11.4 +/- 1.3 and 7.9 +/- 0.8 ng.mL(-1) respectively vs. 10.5 +/- 0.8 ng.mL(-1) in control mares). In conclusion, Antarelix seems more efficient than Cetrorelix for postponing ovulation in mares. The role of LH in antral follicular development before the preovulatory stage is confirmed.     

补脾滋肾汤联合针灸治疗多囊卵巢综合征不孕症的临床疗效观察

摘要 目的：观察补脾滋肾汤联合针灸治疗多囊卵巢综合征（PCOS）不孕症的临床疗效。方法：选择2018年9月~2020年9月就诊的120例PCOS不孕症患者,随机分为观察组和对照组各60例。均给予口服枸橼酸氯米芬基础治疗,观察组在基础治疗上增加补脾滋肾汤联合针灸治疗,28 d为一个治疗周期,对比两组患者3个疗程后总有效率、中医证候量表评分、BMI（体质量指数）、月经情况、排卵情况、妊娠情况、血清性激素指标[T（睾酮）、LH（促黄体生成激素）、FSH（促卵泡生成激素）]、B超测定子宫内膜容受性指标[子宫内膜厚度、PI（子宫内膜螺旋动脉搏动指数）与RI（阻力指数）]。结果：治疗3个疗程后观察组的临床总有效率为90%（54/60）,高于对照组的83%（50/60）（P<0.05）。经过3个疗程治疗后,两组PCOS不孕症患者中医症候量表评分改善,月经情况改善,两组排卵率、妊娠率提高,且观察组高于对照组（P<0.05）。治疗3个疗程后,两组BMI、RI、PI、LH、T均下降,且观察组低于对照组（P<0.05）;两组子宫内膜厚度、FSH均增高,且观察组高于对照组（P<0.05）。结论：补脾滋肾汤联合针灸治疗多囊卵巢综合征不孕患者通过中药滋补脾肾、针灸治疗后,有效缓解了临床症状,性激素水平得到调节、体重减轻,提高调经促排卵助孕率,疗效确切。     

Effect of GnRH treatment during the anovulatory season on multiple ovulation rate and on follicular development during the ensuing pregnancy in mares

Seasonally anovulatory mares were injected, i.m., twice daily with a GnRH analogue (GnRH-A), and hCG was given when the largest follicle reached 35 mm in diameter. In Exp. 1, treatment was initiated on 23 December when the largest follicle per mare was less than or equal to 17 mm. An ovulatory response (ovulation within 21 days) occurred in 17 of 30 (57%) GnRH-A-treated mares on a mean of 15.8 days. The shortest interval to ovulation in control mares (N = 10) was 57 days. The diameter of the largest follicle first increased significantly 6 days after start of treatment. In Exp. 2, treatment was begun on 15 January and mares were categorized according to the largest follicle at start of treatment. The proportion of mares ovulating within 21 days increased significantly according to initial diameter of largest follicle (less than or equal to 15 mm, 9/25 mares ovulated; 15-19 mm, 13/21; 20-24 mm, 20/24; greater than 25 mm, 3/3). The multiple ovulation rate was greater (P less than 0.01) for treated mares (27/86 mares had multiple ovulations) than for control mares (2/35). Treated mares in which the largest follicle at start of treatment was greater than or equal to 25 mm had a higher (P less than 0.01) multiple ovulation rate (9/14) than did mares in which the largest follicle was less than 25 mm (18/72). The pregnancy rate for single ovulators was not different between control mares (26/30 pregnant mares) and treated mares (43/54).(ABSTRACT TRUNCATED AT 250 WORDS)     

Comparison of equine pituitary extract and follicle stimulating hormone for superovulating mares

Sixty light-horse, nonlactating mares were used to compare the efficacy of equine pituitary extract versus follicle stimulating hormone (FSH-P) for inducing multiple ovulations. On Day 12 of diestrus, mares were assigned to receive 1) no treatment, controls; 2) subcutaneous injections of 750 Fevold rat units of equine pituitary extract once daily; or 3) intramuscular injection of 150 mg of FSH-P twice daily. Ultrasound was used twice daily to visualize follicular changes and ovulation. For mares in Groups 2 and 3, treatment was initiated when two or more follicles > 20 mm were detected, and it continued until all large follicles (> 30 mm) had ovulated or regressed. Five milligrams of prostaglandin F(2)alpha (PGF(2)) were administered to mares in Groups 2 and 3 on the first day of treatment. Human chorionic gonadotropin (3,300 IU) was given to all groups of mares during estrus when a 35-mm follicle was detected. Ovulation rate was greater (P < 0.05) for mares treated with pituitary extract (2.2) compared to FSH-P treatment (1.6) or no treatment (1.0). Thirteen of 18 mares treated with the extract had more than one ovulation versus only four of nine FSH-treated mares. Mares in the pituitary extract group were given injections for an average of 6.4 d compared to 6.8 d (13.7 injections) for FSH-treated mares. Intervals to estrus and ovulation from initial injection of extract were 2.9, 7.6; and 2.6, 9.2 d for FSH-treated mares. The mean number of medium-sized follicles (25 to 30 mm) was greater (P < 0.05) in extract-treated mares compared to the FSH-treated mares. Both extract and FSH increased (P < 0.05) the number of follicles > 30 mm and the size of the second largest follicle 1 and 2 d prior to ovulation when compared to controls. Overall, mares with multiple ovulations had more (P < 0.05) follicles 25 to 30 mm and > 30 mm on Day -6 through -1 (Day 0 = day of ovulation) than single ovulating mares. Those mares that had multiple ovulations had less (P < 0.05) size difference between the largest and second largest follicle when compared to single ovulating mares. In summary, FSH-P at the one dose studied was less effective than equine pituitary extract in inducing follicular activity and multiple ovulation in the mare.     

Evaluation of three equine FSH superovulation protocols in mares

Superovulation could potentially increase embryo recovery for immediate transfer or cryopreservation. The objectives were to evaluate the effect of pretreatment with progesterone and estradiol (P+E) on follicular response to eFSH and compare doses of eFSH and ovulatory agents on follicular development and ovulation in mares. In Experiment 1, 40 mares were assigned to one of four treatment groups. Group 1 consisted of untreated controls. Group 2 mares were administered eFSH without pretreatment with P+E. Group 3 mares were administered P+E for 10 days starting in mid-diestrus followed by eFSH therapy. Group 4 mares were administered P+E for 10 days followed by eFSH therapy. All treated mares were administered 12.5mg eFSH twice daily and prostaglandins were given on the second day of eFSH therapy. Mares were bred with fresh semen the day of hCG administration and with cooled semen the following day. The numbers of preovulatory follicles and ovulations were lower for mares treated with P+E prior to eFSH treatment. Pretreatment with P+E in estrus also resulted in a lower embryo recovery rate per ovulation compared to the other two eFSH treatment groups. In Experiment 2, two doses of eFSH (12.5 and 6.25mg) and two ovulation-inducing agents (hCG and deslorelin) were evaluated. The number of preovulatory follicles was greater for mares given 12.5mg of eFSH compared to mares given 6.25mg. Number of ovulations was greatest for mares given 12.5mg of eFSH twice daily followed by administration of hCG. Embryo recovery per flush was similar among treatment groups, but the percent of embryos per ovulation was higher for mares given the low dose of eFSH. In summary, there was no advantage to giving P+E prior to eFSH treatment. In addition, even though the lower dose of eFSH resulted in fewer ovulations, embryo recovery per flush and embryo recovery per ovulation were similar or better for those given the lower dose of eFSH.     

Urinary eCG patterns in the mare during pregnancy

Blood and urine samples collected from 12 mares at frequent intervals from 25 to 210 d of pregnancy were analyzed for equine chorionic gonadotropin (eCG). Blood and urine samples were collected daily through two consecutive ovulatory periods from five cyclic mares for comparative purposes. Separate radioimmunoassays (RIA) were developed to detect eCG in the urine and plasma. A simple and quick commercial dipstick enzyme-linked immunospecific assay (ELISA), developed for eCG in the blood, was also utilized in this study to detect eCG in the urine. In the 12 pregnant mares, eCG concentrations in both the plasma and urine as detected by RIA rose significantly on Day 40, peaked by Day 60 and slowly dropped to low levels by Day 200. The dipstick ELISA appeared more reliable for eCG in the plasma than in the urine of the five pregnant mares tested. However, on peak days (50 to 60), both the plasma and urine tested positive in all five mares. Similar eCG profiles were observed when urine samples from seven of the mares were assayed in the dipstick ELISA and RIA. The highest percentage of mares (86%) were positive for eCG by ELISA between Days 65 and 85. The highest concentration of eCG in the urine as detected by RIA was observed between Days 55 and 90. ECG-like immunoactivity was not detected by the ELISA in the urine of cyclic mares, but the RIA showed variable patterns with increases in immunoactivity that could not be correlated with physiological events. In summary, eCG in urine follows a similar profile as the eCG in plasma of mares during their first trimester of pregnancy.